Cite
Virtual screening, drug-likeness analysis, and molecular docking study of potential severe acute respiratory syndrome coronavirus 2 main protease inhibitors.
MLA
Nedeljković, Nikola V., et al. “Virtual Screening, Drug-Likeness Analysis, and Molecular Docking Study of Potential Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors.” Turkish Journal of Chemistry, vol. 46, no. 1, Sept. 2021, pp. 116–46. EBSCOhost, https://doi.org/10.3906/kim-2103-20.
APA
Nedeljković, N. V., Nikolić, M. V., Stanković, A. S., Jeremić, N. S., Tomović, D. L., Bukonjić, A. M., Radić, G. P., & Mijajlović, M. Ž. (2021). Virtual screening, drug-likeness analysis, and molecular docking study of potential severe acute respiratory syndrome coronavirus 2 main protease inhibitors. Turkish Journal of Chemistry, 46(1), 116–146. https://doi.org/10.3906/kim-2103-20
Chicago
Nedeljković, Nikola V, Miloš V Nikolić, Ana S Stanković, Nevena S Jeremić, Dušan Lj Tomović, Andriana M Bukonjić, Gordana P Radić, and Marina Ž Mijajlović. 2021. “Virtual Screening, Drug-Likeness Analysis, and Molecular Docking Study of Potential Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors.” Turkish Journal of Chemistry 46 (1): 116–46. doi:10.3906/kim-2103-20.